Board Certified Gynecologic Oncologist
550 16th Street, 7th Floor, Box 4065
|Academic Phone:||415-885-7204 / 415-885-7561|
Dr. Stefanie Ueda's primary interests at UCSF are ovarian cancer, robotic surgery, uterine serous cancer, biologically targeted therapies and international health. During the last two years she has pioneered a program in Uganda's Mulago Hospital and Makerere University aimed at improving cancer care and surgical training in an effort to treat the 80-100 patients seen on the oncology ward each week. She is helping to revolutionize treatment and outcomes with the introduction of twice-weekly ward rounds, a follow-up outpatient clinic and telemedicine consultation via e-mail and Skype. In spite of limited resources, she hopes to introduce chemotherapy and improve laparoscopic and surgical capabilities.
|Year||Institution & Location||Degree||Field of Study|
|1997||Stanford University, Stanford, CA||B.A.||English|
|2002||New York University School of Medicine, New York, NY||M.D.||Medicine|
|2006||University of Hawaii, Honolulu, HI||Residency||Obstetrics & Gynecology|
|2010||Johns Hopkins School of Medicine, Baltimore, MD||Fellowship||Gynecologic Oncology|
Achievements & Recognition
HERA Foundation Award in Ovarian Cancer Research
Entertainment Industry Foundation Award in Ovarian Cancer Research
Ueda SM, Yap, KL, Davidson, B et al. Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas. J Oncology 2010;2010:285191.
Krill LS, Ueda SM, Gerardi M, Bristow RE. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Article in press for Gynecol Oncol. 2011 Feb; 120(2):220-3
Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Nickles-Fader A. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol 2001;55(3):255-60.
Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol 2011;122(2):319-23.
Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I non-invasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer 2012;22(2):273-9.